Notice: This company has been marked as potentially delisted and may not be actively trading. Roth CH Acquisition I (ROCH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends ROCH vs. IPXX, RRAC, MBAV, BACQ, VACH, SIMA, CDRO, POLE, VCIC, and LPAAShould you be buying Roth CH Acquisition I stock or one of its competitors? The main competitors of Roth CH Acquisition I include Inflection Point Acquisition Corp. II (IPXX), Rigel Resource Acquisition (RRAC), M3-Brigade Acquisition V (MBAV), Bleichroeder Acquisition Corp I - Class A (BACQ), Voyager Acquisition (VACH), SIM Acquisition Corp. I (SIMA), Codere Online Luxembourg (CDRO), Andretti Acquisition Corp. II (POLE), Vine Hill Capital Investment (VCIC), and Launch One Acquisition (LPAA). Roth CH Acquisition I vs. Inflection Point Acquisition Corp. II Rigel Resource Acquisition M3-Brigade Acquisition V Bleichroeder Acquisition Corp I - Class A Voyager Acquisition SIM Acquisition Corp. I Codere Online Luxembourg Andretti Acquisition Corp. II Vine Hill Capital Investment Launch One Acquisition Roth CH Acquisition I (NASDAQ:ROCH) and Inflection Point Acquisition Corp. II (NASDAQ:IPXX) are both small-cap companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, community ranking, media sentiment and analyst recommendations. Which has preferable earnings and valuation, ROCH or IPXX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoth CH Acquisition IN/AN/AN/AN/AN/AInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/A Does the media refer more to ROCH or IPXX? In the previous week, Inflection Point Acquisition Corp. II had 3 more articles in the media than Roth CH Acquisition I. MarketBeat recorded 3 mentions for Inflection Point Acquisition Corp. II and 0 mentions for Roth CH Acquisition I. Inflection Point Acquisition Corp. II's average media sentiment score of 1.58 beat Roth CH Acquisition I's score of 0.00 indicating that Inflection Point Acquisition Corp. II is being referred to more favorably in the news media. Company Overall Sentiment Roth CH Acquisition I Neutral Inflection Point Acquisition Corp. II Very Positive Do institutionals and insiders believe in ROCH or IPXX? 42.2% of Roth CH Acquisition I shares are held by institutional investors. 20.0% of Inflection Point Acquisition Corp. II shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community prefer ROCH or IPXX? Roth CH Acquisition I and Inflection Point Acquisition Corp. II both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRoth CH Acquisition IN/AN/AInflection Point Acquisition Corp. IIN/AN/A Is ROCH or IPXX more profitable? Company Net Margins Return on Equity Return on Assets Roth CH Acquisition IN/A N/A N/A Inflection Point Acquisition Corp. II N/A N/A N/A SummaryInflection Point Acquisition Corp. II beats Roth CH Acquisition I on 3 of the 4 factors compared between the two stocks. Get Roth CH Acquisition I News Delivered to You Automatically Sign up to receive the latest news and ratings for ROCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ROCH vs. The Competition Export to ExcelMetricRoth CH Acquisition IHolding & Other Investment Offices Industry SectorNASDAQ ExchangeMarket Cap$93.03M$487.29M$1.99B$9.14BDividend YieldN/A7.36%14.04%3.98%P/E RatioN/A2.6210.9017.66Price / SalesN/A134.859,765.8481.09Price / CashN/A69.0721.4237.71Price / BookN/A4.892.494.73Net IncomeN/A$35.97M-$909.82M$225.42M Roth CH Acquisition I Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ROCHRoth CH Acquisition IN/A$9.38-3.9%N/A+162.5%$93.03MN/A0.00N/AHigh Trading VolumeIPXXInflection Point Acquisition Corp. IIN/A$12.35+4.2%N/A+22.2%$370.31MN/A0.00N/AShort Interest ↓News CoverageGap UpRRACRigel Resource AcquisitionN/A$11.50flatN/AN/A$368.81MN/A0.002,021MBAVM3-Brigade Acquisition VN/A$10.09-0.1%N/AN/A$362.64MN/A0.00N/ABACQBleichroeder Acquisition Corp I - Class AN/A$9.92+0.1%N/AN/A$334.90MN/A0.00N/AVACHVoyager AcquisitionN/A$10.07-0.1%N/AN/A$318.41MN/A0.00N/ASIMASIM Acquisition Corp. IN/A$10.11+0.2%N/AN/A$309.89MN/A0.00N/ACDROCodere Online Luxembourg2.1598 of 5 stars$6.58-0.3%$10.00+52.0%+54.3%$298.06M$139.12M0.00230POLEAndretti Acquisition Corp. IIN/A$10.03+0.0%N/AN/A$295.99MN/A0.00N/APositive NewsVCICVine Hill Capital InvestmentN/A$10.08+0.0%N/AN/A$295.50MN/A0.00N/APositive NewsLPAALaunch One AcquisitionN/A$10.07-0.1%N/AN/A$289.51MN/A0.00N/APositive News Related Companies and Tools Related Companies Inflection Point Acquisition Corp. II Competitors Rigel Resource Acquisition Competitors M3-Brigade Acquisition V Competitors Bleichroeder Acquisition Corp I - Class A Competitors Voyager Acquisition Competitors SIM Acquisition Corp. I Competitors Codere Online Luxembourg Competitors Andretti Acquisition Corp. II Competitors Vine Hill Capital Investment Competitors Launch One Acquisition Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ROCH) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roth CH Acquisition I Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roth CH Acquisition I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.